UY26855A1 - Método para la fabricación de anagrelida - Google Patents

Método para la fabricación de anagrelida

Info

Publication number
UY26855A1
UY26855A1 UY26855A UY26855A UY26855A1 UY 26855 A1 UY26855 A1 UY 26855A1 UY 26855 A UY26855 A UY 26855A UY 26855 A UY26855 A UY 26855A UY 26855 A1 UY26855 A1 UY 26855A1
Authority
UY
Uruguay
Prior art keywords
dihalo
manufacture
dihalobenzaldehydes
quinazolin
ones
Prior art date
Application number
UY26855A
Other languages
English (en)
Inventor
Philip Charles Lang
Roxanne P Spencer
Wen-Lung Yeh
Michael Joseph Roth
Original Assignee
Shire Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Us Inc filed Critical Shire Us Inc
Publication of UY26855A1 publication Critical patent/UY26855A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/08—Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporcionan métodos para hacer ciertas 6,7 dihalo-1,5- dihidroímidazo (2,1-b) quinazolin-2(3H)-onas , a partir de 2,3 - dihalobenzaldehídos. Además se proporciona un método para hacer las etil N-(2,3 - dihalo-5- nitrobencil) glicinas intermediarias, a partir de 2,3 - dihalobenzaldehidos, y para reducir los compuestos de glicina usando ya sea SnCl2 o un catalizador especialmente definido. Se proporciona también un método de ciclización para formar las 6,7- dihalo-1, 5- dihidromidazo(2,1-b) quinazolin -2(3H)-onas deseadas, a partir de los correspondientes compuestos de iminoquinazolina. Estos métodos son particularmente adecuados en la fabricación de Anagrelida base.
UY26855A 2000-07-26 2001-07-26 Método para la fabricación de anagrelida UY26855A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/625,962 US6388073B1 (en) 2000-07-26 2000-07-26 Method for the manufacture of anagrelide

Publications (1)

Publication Number Publication Date
UY26855A1 true UY26855A1 (es) 2002-02-28

Family

ID=24508359

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26855A UY26855A1 (es) 2000-07-26 2001-07-26 Método para la fabricación de anagrelida

Country Status (14)

Country Link
US (2) US6388073B1 (es)
EP (6) EP1700859A3 (es)
AR (1) AR029995A1 (es)
AT (1) ATE397608T1 (es)
AU (1) AU7267501A (es)
CA (1) CA2417001C (es)
DE (1) DE60134344D1 (es)
DK (1) DK1373268T3 (es)
ES (1) ES2307630T3 (es)
PT (1) PT1373268E (es)
SI (1) SI1373268T1 (es)
TW (1) TWI309651B (es)
UY (1) UY26855A1 (es)
WO (1) WO2002008228A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216037A2 (en) * 1999-09-21 2002-06-26 Emory University Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
US6823351B1 (en) * 2000-05-15 2004-11-23 Sun Microsystems, Inc. Work-stealing queues for parallel garbage collection
EP2799555B1 (en) 2002-03-13 2017-02-22 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
DE10301105B4 (de) * 2003-01-09 2005-11-24 Chemisch-Pharmazeutisches Labor, Rolf Sachse Gmbh Verwendung von 2-Amino-2H-chinazolin-Derivaten zur Behandlung von myeloproliferativen Erkrankungen, Bluthochdruck und Bronchodilation
CA2513708C (en) * 2003-01-23 2011-01-04 Shire Holdings Ag Formulation and methods for the treatment of thrombocythemia
AT412873B (de) * 2004-02-20 2005-08-25 Aop Orphan Pharmaceuticals Ag Verfahren zur herstellung von anagrelid hydrochlorid
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
US8304420B2 (en) * 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8133996B2 (en) * 2007-02-06 2012-03-13 Cipla Limited Process for the preparation of ethyl-N-(2,3-dichloro-6-nitrobenzyl)glycine hydrochloride
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
GB0822970D0 (en) 2008-12-17 2009-01-21 Shire Llc Process for the preparation of anagrelide and analogues
GB201004495D0 (en) 2010-03-18 2010-05-05 Shire Llc Subtituted quinazolines
GB201017783D0 (en) 2010-10-21 2010-12-01 Shire Llc Process for the preparation of anagrelide and analogues thereof
CN103254197A (zh) * 2013-05-29 2013-08-21 黑龙江大学 一种盐酸阿那格雷的制备方法
CN107903217B (zh) * 2017-11-16 2021-11-23 湖北省宏源药业科技股份有限公司 一种阿那格雷杂质b的制备方法
CN111072575A (zh) * 2019-12-28 2020-04-28 深圳市祥根生物科技有限公司 一种阿那格雷杂质c的制备方法
WO2024180371A1 (en) * 2023-03-02 2024-09-06 Mohammadi Ali Synthesis and purification of the active pharmaceutical ingredient of anagrelide hydrochloride and all its intermediates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31617E (en) 1972-02-04 1984-06-26 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3932407A (en) 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4146718A (en) 1978-04-10 1979-03-27 Bristol-Myers Company Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
US4208521A (en) 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
CA1131631A (en) * 1979-06-20 1982-09-14 Madhukar S. Chodnekar Quinazoline derivatives and pharmaceutical preparations
EP0028489B1 (en) 1979-11-05 1983-10-05 Beecham Group Plc Enzyme derivatives, and their preparation
US4357330A (en) 1981-07-30 1982-11-02 Bristol-Myers Company Pharmaceutical compositions
GB8824496D0 (en) 1988-10-19 1988-11-23 Beecham Group Plc Process
JPH02157282A (ja) * 1988-12-12 1990-06-18 Wakunaga Pharmaceut Co Ltd 新規ピリドベンゾオキサジン誘導体
US5391737A (en) * 1991-05-22 1995-02-21 Egis Gyogyszergyar Process for the preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2[3H]-one
CA2171073A1 (en) 1995-12-04 1997-06-05 Philip C. Lang Process for the preparation of ethyl-n-(2,3 dichloro-6- nitrobenzyl) glycine

Also Published As

Publication number Publication date
DK1373268T3 (da) 2008-10-13
ES2307630T3 (es) 2008-12-01
EP1700843A3 (en) 2010-02-24
EP1373268A2 (en) 2004-01-02
US20030060630A1 (en) 2003-03-27
WO2002008228A2 (en) 2002-01-31
SI1373268T1 (sl) 2008-12-31
AU7267501A (en) 2002-02-05
PT1373268E (pt) 2008-09-15
EP1700841A3 (en) 2010-02-24
CA2417001A1 (en) 2002-01-31
CA2417001C (en) 2010-04-20
TWI309651B (en) 2009-05-11
EP1700840A2 (en) 2006-09-13
AR029995A1 (es) 2003-07-23
EP1700842A3 (en) 2010-02-24
EP1700843A2 (en) 2006-09-13
EP1700859A2 (en) 2006-09-13
EP1700859A3 (en) 2010-02-24
US6653500B2 (en) 2003-11-25
WO2002008228A3 (en) 2003-10-09
EP1700841A2 (en) 2006-09-13
EP1700840A3 (en) 2010-02-24
DE60134344D1 (de) 2008-07-17
EP1373268B1 (en) 2008-06-04
EP1700842A2 (en) 2006-09-13
ATE397608T1 (de) 2008-06-15
US6388073B1 (en) 2002-05-14

Similar Documents

Publication Publication Date Title
UY26855A1 (es) Método para la fabricación de anagrelida
EA200200748A1 (ru) СОЕДИНЕНИЯ N-(5,7-ДИМЕТОКСИ[1,2,4]ТРИАЗОЛО [1,5-а]ПИРИМИДИН-2-ИЛ) АРИЛСУЛЬФОНАМИДА И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ГЕРБИЦИДОВ
DE60117972D1 (de) Neue kristalline form einer triazolo(4,5-d)pyrimidin-verbindung
ES2158513T3 (es) Compuestos de n-((1,2,4)triazoloazinil)bencenosulfonamida y piridinsulfonamida, y su uso como herbicidas.
EA201000496A1 (ru) Замещенное соединение миноциклина, способ получения замещенных соединений миноциклина (варианты)
TR199902406T2 (xx) Kristalli cefdinir amin tuz.
DK1169314T3 (da) Krystallinsk base af citalopram
DK1386917T3 (da) Mellemprodukter til fremstilling af visse triazolopyrimidiner som P2T antagonister
DOP2002000447A (es) 1-alquil o 1-cicloalquiltriazolo [4,3-a] quinazolin-5 onas como inhibidores de fosfodiesterasas
PE106300A1 (es) Imidazoquinoxalinas como inhibidores de la proteina tirosina cinasa
GT199900029A (es) Compuestos heterociclicos como inhibidores de enzimas rotamasas.
AR020114A1 (es) Proceso para la preparacion de derivados de quinazolina sustituida y compuestos para su exclusivo uso en dicho proceso
ATE250601T1 (de) Prozess zur herstellung der kristallinen form i von cabergolin
DK1066292T3 (da) Metallocorrinoider som biologisk kompatible bærere af farmakologiske midler
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
SG125971A1 (en) Variable water hydrates of zaleplon and method forthe preparation thereof
IT1202444B (it) Procedimento per produrre corpi sagomati,porosi di forma allungata
NO20030978D0 (no) Behandling av diuresedysfunksjon
AR005619A1 (es) Procedimiento para preparar compuestos dicetonicos
EA200401234A1 (ru) Способ приготовления клопидогрела
EP1278817A4 (en) METHOD FOR PRODUCING A SILVER-CONTAINING CANDLE
EA200500188A1 (ru) Кристаллические формы оланзапина и способы их получения
DK1251132T3 (da) Fremgangsmåde til syntese af (3aS)-5,5-dioxo-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]-benzothiadiazin
PE20020614A1 (es) Derivados de pirrolotriazolopirimidinona como inhibidores de fosfodiesterasa 5
DK0946537T3 (da) Fremgangsmåde til stereoselektiv fremstilling af nitroenaminforbindelser

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140519